Magneto Thrombectomy Solutions
Focus: Magneto Thrombectomy Solutions is a public biotechnology company headquartered in Israel focused on innovative mechanical thrombectomy devices for acute ischemic stroke and pulmonary embolism. With 5,000+ employees, the company operates at significant scale in the medical device/interventional therapy space.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
About Magneto Thrombectomy Solutions
AI assessmentNot HiringNo open roles listed right now. Follow Magneto Thrombectomy Solutions to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Magneto Microcatheter
Ischemic StrokeClinical Trials (1)
NCT04466033Evaluation of the Safety and Performance of Magneto Microcatheter
N/AHelp build intelligence for Magneto Thrombectomy Solutions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.